CHRISTINE FARREN: Open Payments
NPI 1790137644 · EGG HARBOR TOWNSHIP, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 26 payments from 14 companies in 2025. Trend: 2023 $286 · 2024 $764 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| Gilead Sciences, Inc. | 3 | $53 |
| ABBVIE INC. | 3 | $49 |
| Celgene Corporation | 2 | $37 |
| Karyopharm Therapeutics Inc. | 2 | $34 |
| Genentech USA, Inc. | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Geron Corporation | 2 | $32 |
| PFIZER INC. | 1 | $23 |
| Incyte Corporation | 1 | $22 |
Products named: KISQALI, Trodelvy, REBLOZYL, IMBRUVICA, XPOVIO, OPDIVO, RYTELO, IBRANCE.
Industry payments across NJ — which companies pay providers there.
